Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 05, 2025 (GLOBE NEWSWIRE) -- Faruqi & Far ...

Core Viewpoint - Nutex Health Inc. is facing a class action lawsuit due to allegations of securities fraud related to its dealings with HaloMD, which reportedly engaged in fraudulent activities to benefit Nutex financially [3][5]. Group 1: Allegations and Impact - On July 22, 2025, a report by Blue Orca Capital claimed that HaloMD was involved in a fraudulent scheme that resulted in significant financial losses for insurance companies, leading to a decline in Nutex's share price by approximately 10.05% [3]. - Following Nutex's announcement on August 14, 2025, regarding a delay in filing its quarterly report due to accounting adjustments, the company's share price fell by about 16.39% [4]. Group 2: Details of the Lawsuit - The lawsuit covers investors who purchased Nutex securities from August 8, 2024, to August 14, 2025, alleging that Nutex made misleading statements and failed to disclose critical information regarding its financial practices and the sustainability of its revenue [5]. - Specific allegations include that Nutex overstated its financial health, mismanaged stock-based compensation obligations, and failed to adequately address weaknesses in its internal controls over financial reporting [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nutex Health Inc. securities between August 8, 2024, and August 14, 2025, about the October 21, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Nutex securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by October 21, 2025 [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. Group 2: Allegations Against Nutex - The lawsuit alleges that Nutex made false and misleading statements, including claims about its financial reporting and internal controls [4]. - Specific allegations include that Nutex's revenues from a third-party vendor, HaloMD, were unsustainable due to fraudulent activities [4]. - The lawsuit claims that Nutex overstated its ability to remediate weaknesses in its financial reporting, leading to improper accounting of stock-based compensation obligations [4].

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

LOS ANGELES, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR NUTEX INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECO ...

Core Points - A class action lawsuit has been filed against Nutex Health Inc. for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the Class Period from August 8, 2024, to August 14, 2025 [8] - The lawsuit claims that Nutex engaged in fraudulent activities through its partnership with HaloMD, leading to unsustainable revenue and overstated financial health [3] - Investors who suffered losses during the specified period are encouraged to contact Bragar Eagel & Squire for legal options [4] Allegation Details - The complaint alleges that Nutex's management made false statements about the company's business and operations, including the success of its arbitration results with HaloMD [3] - It is claimed that Nutex overstated its ability to remediate internal control weaknesses and improperly classified stock-based compensation obligations [3] - The allegations suggest that these misrepresentations increased the risk of delayed financial reporting to the SEC and inflated the company's financial prospects [3] Next Steps - Investors who purchased Nutex shares and experienced losses are invited to reach out to the law firm for more information or to discuss their rights [4] - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 21, 2025 [8]

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a ...

DEADLINE: October 27, 2025 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. LifeMD raised its guidance for fiscal year 2025 while ignoring important factors like customer acquisition costs. Based on these facts, LifeMD's public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate . NEXT STEPS FOR SHAREHOLDERS : Once you register as a shareholder who purchas ...

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for alleged violations of securities laws, specifically for making false and misleading statements to the market and failing to maintain adequate internal controls [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from August 8, 2024, to August 14, 2025, with a deadline for lead plaintiff appointments set for October 21, 2025 [2]. - The complaint alleges that Nutex was involved in a scheme to defraud insurance companies, leading to materially misleading public statements throughout the class period [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the specified class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments, although this is not a requirement for recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress, with no cost or obligation to participate [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4].

NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, inclusive. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Nutex Health Inc. (NASDAQ: NUTX)?Did you purchase your shares between August 8, 2024 and August 14, ...